Roche Workers Eligible for $2.6 Million in State Grants [the Record

Roche Workers Eligible for $2.6 Million in State Grants [the Record (Hackensack, N.J.)]

From Record (Hackensack, NJ) (September 28, 2012)

Sept. 28--The Christie administration is setting aside $2.6 million in grants to retrain and help find new employment for workers, including those at Roche, who have lost pharmaceutical-related jobs since 2010.

Qualified candidates may receive up to $5,000 in education grants or other opportunities, state officials said Thursday. The funds are to assist workers laid-off from specific pharmaceutical operations to land jobs or to obtain training to get into growing industries. The services available include skills assessment, individual career counseling and occupational skills training.

In addition to idled workers from Roche in Nutley, former employees at Bristol Myers Squibb, Johnson & Johnson, Merck/Schering-Plough and Pfizer are also eligible for the grants. Roche is in the midst of laying off 1,000 full-time workers because it is closing its Nutley facility, whose closure was announced in June.

The funding is being made available to New Jersey from the latest allocation of a $3.6 million National Emergency Grant that the state Department of Labor and Workforce Development (LWD) initially applied for and obtained in October 2010 from the U.S. Department of Labor. The money is aimed at ensuring that displaced pharmaceutical workers would get assistance and job training.

An initial $1 million installment received in 2010 had been tied only to training for pharma workers who had been laid off from eight specific locations. But the Labor Department agreed to the state’s request that the list of qualifying locations be expanded, which means many more displaced pharma workers may be eligible for this latest allocation of training funds.

------

(c)2012 The Record (Hackensack, N.J.)

Visit The Record (Hackensack, N.J.) at www.NorthJersey.com

Distributed by MCT Information Services
 

Posted: September 2012


View comments

Hide
(web2)